Avencia Sanchez-Mejias

Description

PhD in Molecular Biology and Master in Biomedical Research from the University of Seville. She has had a solid career in clinical genetics, molecular oncology and synthetic biology at research centres tied to university hospitals in several countries, including Spain, the United States and Singapore.

She did her PhD at the Institute of Biomedicine of Seville and post-doc at the National University of Singapore and University of Miami Miller School of Medicine. In 2018, she joined the Translational Synthetic Biology Lab at Pompeu Fabra University, led by Dr Marc Güell.

In recent years, she has focused on transferring the knowledge generated in these institutions to society through her entrepreneurial project, Integra Tx. Founded with Dr Marc Güell, Integra Tx is a Barcelona-based company that is creating latest-generation gene-editing tools to make advanced therapies safer and more effective.

She is committed to helping develop female talent and encouraging coming generations to go into STEM fields. In 2021, she was chosen to take part in the Academy for Women Entrepreneurs programme promoted by Foment del Treball and the US Consulate in Barcelona.